A Smart + Strong Site
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Post-Conference Report Provides HIV Cure Roadmap
Life Expectancy With HIV Increases Dramatically
Improper Use of a Neti Pot Can Be Fatal
Animal Studies Suggest Anti-Reservoir Drugs May Help 'Functionally Cure' HIV
Tenofovir Microbicide Gel Falters in Major HIV Prevention Study
Gold Drug Shows HIV Eradication Potential
New Studies Under Way of Sangamo's Possible 'Functional Cure' Gene Therapy
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
Aging & HIV
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

April 23, 2008

Insulin Resistance Predicts Heart Disease and Stroke Risk

People with insulin resistance—whereby cells become less sensitive to insulin, the hormone that helps control blood sugar—were more likely to have physical symptoms associated with heart disease and stroke risk than people without insulin resistance, according to a study published in the April 23 issue of AIDS.

Diabetes is a known risk factor for the development of heart disease, and insulin resistance is often a precursor to diabetes. Though no studies have found diabetes to be more common in people living with HIV compared with HIV-negative people, several antiretroviral (ARV) treatments have been associated with insulin resistance and, with it, a potentially higher risk of diabetes.

Insulin resistance has also been found to be associated with cardiovascular disease—which includes heart damage and stroke—in studies involving HIV-negative men and women. To determine if this link also exists among HIV-positive people, Kristen Mondy, MD, of the Washington University School of Medicine in St. Louis, and her colleagues compared the results of metabolic and cardiovascular testing in 50 HIV-positive and 50 HIV-negative patients.

The study volunteers were matched in terms of age and traditional heart disease risk factors. Fifty percent of the patients were African American and 34 percent were women. All of the HIV-positive patients were on ARV therapy, their average CD4 count was 547, and 90 percent had a viral load of less than 50 copies. Cardiovascular risk was determined by looking for endothelial dysfunction— inflammation of the lining of blood vessels—and increased thickness of the carotid artery in the neck, a sign of dangerous blood vessel narrowing caused by a buildup of cholesterol-containing plaque.  

Though the HIV-positive patients in general were no more likely than HIV-negative patients to have thickening of the carotid artery or endothelial inflammation, HIV-positive patients diagnosed with insulin resistance were. Another predictor of carotid artery thickness was higher consumption of alcohol, while predictors of endothelial dysfunction were high blood pressure and higher ratio of belly fat compared with limb fat.

Interestingly, none of the ARV treatments taken by the HIV-positive patients were associated with either insulin resistance or heart disease risk, nor was the length of time that people had taken ARV therapy. Mondy’s team concludes with the recommendation that ongoing large cohort studies evaluate the contribution of insulin resistance to cardiovascular disease risk in people living with HIV.

Search: heart attack, stroke, cardiovascular, insulin, diabetes, Kristen, Mondy, Washington University, antiretroviral


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

       


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
Clinical Trials
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine


    dambitious
    Baltimore Co.
    Maryland


    JoeYorker
    New York
    New York


    second2none
    Seattle
    Washington


    Dreaming
    Montgomery County
    Maryland
Click here to join POZ Personals!
Conference Coverage

6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011)
Rome, Italy
July 17 - 20, 2011


18th Conference on Retroviruses and Opportunistic Infections (CROI 2011)
Boston, MA
February 27 - March 2, 2011


XVIII International AIDS Conference
Vienna, Austria
July 18-23, 2010

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2012 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.